IRCT20170128032241N2已完成2 期
Evaluation of safety and efficacy of oral curcuden on remitting and relapsing multiple sclerosis patients (RRMS): clinical trial study of Phase A2
Alborz Nanomed Tech Co.0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •RRMS patients who will receive first-line treatment drugs for one year
- •Have at least one relapse or active lesion
- •At least one month has passed since the last attack of the disease
- •At least one month ha passed from the patient's corticosteroids
- •Average age of 18 to 60 years
- •0 No curcumin contraindications
排除标准
- •Progressive MS patients
- •Patients who have contraindicated curcumin or similar substances
- •The presence of any internal or systemic illness (such as anemia or liver problems)
研究者
相似试验
已完成
4 期
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
已完成
不适用
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaCTRI/2021/08/035350Department of Dermatology42
尚未招募
3 期
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childreCTRI/2024/02/063274IMS and SUM Hospital
已完成
3 期
Efficacy of N-acetylcysteine in patients with COVID-19covid-19.COVID-19U07.1IRCT20200623047897N1Iran University of Medical Sciences60
尚未招募
不适用
To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.CTRI/2020/12/029904Dr Ruchir M Bhatt